GIGABYTE-TECHNOLOGY
GIGABYTE Technology, an IT pioneer advancing global industries through cloud and AI computing systems, is presenting innovative enterprise computing solutions at MWC 2024, featuring trailblazing servers, green computing solutions, and edge AI technologies, under the theme "Future of COMPUTING." These advancements usher in new possibilities for agile and sustainable IT strategies, enabling industries to harness real-time intelligence across hyperconnected data centers, cloud, edge, and devices, resulting in enhanced efficiency, cost-effectiveness, and competitive advantages, all propelled by the synergies of 5G and AI technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226750501/en/
GIGABYTE Ignites AI and 5G Visions at MWC 2024, Highlighting New Supercomputers, Edge AI and Sustainable IT Upgrades (Photo: Business Wire)
The New Supercomputer Unveiled
GIGABYTE presents G593-ZX1/ZX2, the AI server featuring AMD Instinct™ MI300X 8-GPU, which is a new addition to GIGABYTE’s flagship AI/HPC server series. Other highlighted exhibits include the high-density H223-V10 supporting the NVIDIA Grace Hopper Superchip, the G383-R80 server supporting four AMD Instinct™ MI300A APUs, and a G593 series AI server equipped with the powerful NVIDIA HGX H100 8-GPU.
Adjacent to these trailblazing AI/HPC servers stands the all-flash array storage server, S183-SH0. With the capacity for 32 E1.S NVMe SSDs, it provides hyper-speed data storage, ideal for handling complex AI workloads such as large language models (LLM). Altogether, these servers can be integrated into the supercomputer clusters and 5G framework, serving as the cornerstone of AI-ready infrastructure and driving business and research breakthroughs at exascale.
Flexible Edge Platform for the Next Phase of 5G and AI
At the booth, GIGABYTE introduces a highly adaptable edge server, E263-S30, surrounded by a power supply and motherboard alongside NICs and accelerators from AMD, Broadcom, Intel, and NVIDIA. E263-S30 exemplifies how GIGABYTE’s modular servers cater to a wealth of IT scenarios by upgrading various hardware specifications within a unified chassis. Its flexibility proves instrumental in expediting large-scale 5G network deployments while minimizing maintenance and upgrade costs.
One-Stop Solution for Green IT Upgrades
The dissipation of excess heat from servers emerges as a notable contributor to energy waste. GIGABYTE addresses this challenge by presenting the A1P0-EB0, a large-scale 25U EIA immersion cooling tank, showcasing outstanding server heat dissipation of up to 80kW and a PUE as low as 1.02. GIGABYTE also provides an extensive range of immersion-ready servers, supporting both Intel and AMD processors, and cater to all kinds of workloads. They exemplify how GIGABYTE's comprehensive green computing solutions enable data centers to reduce power consumption and achieve a more favorable total cost of ownership (TCO).
Versatile Enterprise Servers with Robust Networking Capabilities
GIGABYTE presents a diverse server lineup designed for telecom, cloud service providers, enterprises, and SMBs, enabling the establishment of open and secure digital architectures across network environments. The Arm server, R163-P32, boasts its energy-efficient core-dense system, providing operational advantages for large-scale cloud-native workloads.
In AI workloads and edge cloud applications, the R243-EG0 and R143-EG0 servers support AMD EPYC™ 8004 Series processors, providing exceptional performance per watt and suitability for telco environments. For SMB IT solutions, GIGABYTE introduces R113-C10 and R123-X00, equipped with AMD Ryzen™ 7000 and Intel® Xeon® E-2400 processors, ensuring reliable IT operations such as web hosting, hybrid cloud, and data storage.
Highly Accurate Self-Driving Technologies Fueled by Edge AI
Integrating edge technology, AI algorithms, and cutting-edge chips, GIGABYTE's Advanced Driver Assistance Systems (ADAS) and telematics make real-time driving decisions for a safe and intelligent self-driving experience. Providing rich I/O interfaces, they seamlessly integrate with various sensing devices, including cameras, ultrasonic sensors, LiDAR, and mmWave radars, gathering comprehensive environmental data to guide vehicles along the optimal route under dynamic and challenging road conditions.
Visit GIGABYTE’s MWC event page.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226750501/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
